Search
for
Sort by
Research 421–450 of 1000+
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- A review of hyperandrogenism state in polycystic ovarian syndrome
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome?
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach
- lncRNA H19 acts as a ceRNA to regulate the expression of CTGF by targeting miR-19b in polycystic ovary syndrome
- Correlation between Pilomatrixoma and Polycystic Ovary Syndrome (PCOS)
- 7745 Hirsutism in young girls: Beyond PCOS
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- Evaluation of the Efficacy and Threshold of Serum Anti-mullerian Hormone (AMH) Levels for Diagnosis and Prediction of Polycystic Ovary Syndrome (PCOS) Among Indian Women.
- Testosterone (T) secreting tumor or insulin resistance? metformin (M) as a diagnostic (Dx) and therapeutic (Rx) trial
- Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study
- THE ROLE OF METFORMIN IN INDUCTION OF OVULATION IN OBESE INFERTILE PATIENTS WITH POLYCYSTIC OVARY SYNDROME
- Treatment options for polycystic ovary syndrome
- Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis
- 6 Current concepts of polycystic ovary syndrome
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome
- The profile of steroid hormones in human fetal and adult ovaries